Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-089089
Filing Date
2025-06-23
Accepted
2025-06-23 17:21:20
Documents
1
Period of Report
2025-06-23

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4045
  Complete submission text file 0000950170-25-089089.txt   5513
Mailing Address 10955 ALEXANDRIA WAY SUITE 100 SAN DIEGO CA 92121
Business Address 10955 ALEXANDRIA WAY SUITE 100 SAN DIEGO CA 92121 (858) 766-9912
Boundless Bio, Inc. (Issuer) CIK: 0001782303 (see all company filings)

EIN.: 830751369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O BOUNDLESS BIO, INC. 9880 CAMPUS POINT DRIVE, SUITE 120 SAN DIEGO CA 92121
Business Address
Brennan Christine (Reporting) CIK: 0002016488 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41989 | Film No.: 251065923